Inventor
Marie-Odile Roy
Inventor
Paris, FR
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations32%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes12%
Y02PClimate change mitigation technologies in the production or processing of goods12%
G01NInvestigating or analysing materials by determining their chemical or physical properties8%
C07KPeptides4%
C12NMicroorganisms or enzymes4%
PatentTitleYear
10,683,295Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof202010,544,150NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders202010,065,960NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders201810,065,961Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof20189,926,325'NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders'20189,475,814'Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof'20168,871,761'NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders'20148,497,075'Methods of identifying a modulator that inhibits the binding between Epstein-Barr virus induced receptor 2 and cholesterol derived ligands'20137,824,866'Ligand for G-protein coupled receptor GPR72 and uses thereof'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2018Patents assigned to EUROSCREEN SA (5)· patent assignee history
2010–2013Based in Brussels, BG· patent location history
2013Patents assigned to BAUMGARTEN BIRGIT (1)· patent assignee history
2013Patents assigned to CHEN YU (1)· patent assignee history
2013Patents assigned to CHO CHARLES Y (1)· patent assignee history
2014–2020Based in Paris, FR· patent location history
2018–2020Patents assigned to OGEDA SA (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| EUROSCREEN SA | 5 | 2010–2018 |
| OGEDA SA | 5 | 2018–2020 |
| BAUMGARTEN BIRGIT | 1 | 2013 |
| CHEN YU | 1 | 2013 |
| CHO CHARLES Y | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Paris, FR | 7 | 2014–2020 |
| Brussels, BG | 2 | 2010–2013 |